Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections

Journal of Ophthalmic Inflammation and Infection

Table 5 Treatment outcomes of endogenous fungal endophthalmitis

Treatment outcome	Yeast	Mold	p value
Visual Acuity (VA)	n = 39 (51 eyes)	n = 14 (16 eyes)
Presenting mean	1.15 (± 0.78)	1.80 (± 0.80)	0.008
logMAR VA (+/− SD)	1.15 (± 0.78)	1.80 (± 0.80)	0.008
Final mean logMAR	1.05 (± 1.01)	1.97 (± 1.18)	0.005
VA (± SD)	1.05 (± 1.01)	1.97 (± 1.18)	0.005
Change mean	0.11 (± 0.98)	−0.17 (± 1.24)	0.384
logMAR VA (± SD)	0.11 (± 0.98)	−0.17 (± 1.24)	0.384
Multiple IVF injections	17/51 (33.3%)	8/16 (50.0%)	0.229
Retinal detachment	15/49 (30.6%)	2/16 (12.5%)	0.201
Cataract	11/49 (22.4%)	1/16 (6.25%)	0.147
Enucleation	0/51 (0.0%)	4/16 (25.0%)	< 0.001

SD, standard deviation; IVF, intravitreal antifungal; Student’s t test used for statistical analysis of presenting, final, and change in VA; Pearson chi-square test used for statistical analysis of retinal detachment, cataract formation, and enucleation rate.